Ping An Biomedical Co., Ltd., operating primarily through its PRC subsidiary NewBrand, is a supply chain management (SCM) service provider tailored to the apparel and textile industry. The company delivers comprehensive, one-stop solutions that encompass market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. Its operations are divided into two main reportable segments: Yarns and Finished Garments. The majority of the company's revenue is derived from the sale of yarns, which includes pure cashmere, cashmere-mix yarn, merino wool, cotton, and fancy yarn. The company serves a diverse clientele, including brand owners, textile manufacturers, apparel sourcing agents, and online fashion retailers across China, Hong Kong, Cambodia, and Europe. Originally taken public as Majestic Ideal Holdings Limited in July 2025, the company rebranded to Ping An Biomedical Co., Ltd. in September 2025. In early 2026, the company announced a strategic shift by entering into a memorandum to invest in Future Biotechnology Group, signaling an expansion into biopharmaceutical research, medical devices, and healthcare technology, though its core revenue-generating operations remain rooted in textile and apparel supply chain management.
